Schedule 13G Filing for DBV Technologies S.A.

The Schedule 13G filing for DBV Technologies S.A. discloses the beneficial ownership of Ordinary Shares by several entities and individuals, collectively referred to as the 'Reporting Persons.' As of October 10, 2025, Invus Public Equities, L.P. beneficially owns 10,438,485 Ordinary Shares, representing 7.0% of the total outstanding shares. Avicenna Life Sci Master Fund LP owns 1,099,975 Ordinary Shares, representing 0.7% of the total outstanding shares. Raymond Debbane, through various entities, may be deemed to beneficially own a total of 11,538,460 Ordinary Shares, representing 7.8% of the total outstanding shares. The filing certifies that the securities were not acquired for the purpose of influencing the control of the issuer.